On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Advocates for Youth

InstitutionResearch output, impact & collaborations

Advocates for Youth is a institution indexed in ScholarIQ from OpenAlex.

What is known about Advocates for Youth?

ScholarIQrecord summary

Advocates for Youth is a research organisation in Washington D.C., US. OpenAlex records 1,401 works and 20,770 citations for it. 511 researchers list it as their most recent affiliation.

How many works does Advocates for Youth have?

ScholarIQindexed works

Advocates for Youth has 1,401 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Advocates for Youth →

How many citations does Advocates for Youth have?

ScholarIQcitation count

Advocates for Youth has 20,770 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Advocates for Youth →

How many researchers are at Advocates for Youth?

ScholarIQresearcher count

Advocates for Youth has 511 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Advocates for Youth?

ScholarIQavg h-index

Advocates for Youth has an average h-index of 84 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Advocates for Youth?

ScholarIQror

The ROR for Advocates for Youth is on the source record.

Open the ROR →

What is the OpenAlex record for Advocates for Youth?

ScholarIQopenalex

The OpenAlex for Advocates for Youth is on the source record.

Open the OpenAlex →

What is the Wikidata of Advocates for Youth?

ScholarIQwikidata

The Wikidata for Advocates for Youth is on the source record.

Open the Wikidata →

Who are the most-cited researchers behind Advocates for Youth?

ScholarIQtop researchers by citations

Joan H. Schiller · Lung Cancer Treatments and Mutations

521 works43,297 citations

What are the most-cited papers on Advocates for Youth?

ScholarIQmost cited works

Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer

Alan Sandler, Robert J. Gray, Michael C. Perry, Julie R. Brahmer, Joan H. Schiller, Afshin Dowlati, Rogério Lilenbaum, David H. Johnson

New England Journal of Medicine. 20065,784 CitationsOPEN ACCESS

Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer

Mark G. Kris, Ronald B. Natale, Roy S. Herbst, T. J. Lynch, Diane Prager, Chandra P. Belani, Joan H. Schiller, Karen Kelly, H. Spiridonidis, Alan Sandler, Kathy S. Albain, David Cella, Michael Wolf, Steven D. Averbuch, Judith Ochs, Andrea Kay

JAMA. 20032,541 Citations

Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

Mark G. Kris, Bruce E. Johnson, Lynne D. Berry, David J. Kwiatkowski, A. John Iafrate, Ignacio I. Wistuba, Marileila Varella‐Garcia, Wilbur A. Franklin, Samuel L. Aronson, Pei-Fang Su, Yu Shyr, D. Ross Camidge, Lecia V. Sequist, Bonnie S. Glisson, Fadlo R. Khuri, Edward B. Garon, William Pao, Charles M. Rudin, Joan H. Schiller, Eric B. Haura, Mark A. Socinski, Keisuke Shirai, Heidi Chen, Giuseppe Giaccone, Marc Ladanyi, Kelly Kugler, John D. Minna, Paul A. Bunn

JAMA. 20141,758 Citations

Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis

Andrea Ardizzoni, Luca Boni, Marcello Tiseo, Frank V. Fossella, Joan H. Schiller, Marianne Paesmans, Davorin Radosavljević, Adriano Paccagnella, Petr Zatloukal, Paola Mazzanti, D. Bisset, R. Rosell

JNCI Journal of the National Cancer Institute. 2007609 CitationsOPEN ACCESS

Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study

Glenwood Goss, Chris J. O’Callaghan, Ian Lorimer, Ming‐Sound Tsao, Gregory A. Masters, James R. Jett, Martin J. Edelman, Rogério Lilenbaum, Hak Choy, Fadlo R. Khuri, Katherine M.W. Pisters, David R. Gandara, Kemp H. Kernstine, Charles Butts, Jonathan Noble, Thomas A. Hensing, Kendrith M. Rowland, Joan H. Schiller, Keyue Ding, Frances A. Shepherd

Journal of Clinical Oncology. 2013366 CitationsOPEN ACCESS

How much of the research on Advocates for Youth is open access?

ScholarIQopen access share

60%OPEN ACCESS

Gold

Green

Hybrid

Bronze

60%

Closed

40%